|Day Low/High||5.28 / 6.70|
|52 Wk Low/High||3.55 / 6.90|
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADM, AFSI, CKX, EML, EVH, GDEN, MVC, MYGN, PANW, SO, SYKE, TARO Downgrades: IRCP, RMCF, UEIC, WYND Initiations: CALA, FG, MTNB Read on to get TheStreet Quant Ratings' detailed report:
-Calithera to Webcast Corporate Update on March 8, 2018
Investors considering a purchase of Calithera Biosciences, Inc. stock, but tentative about paying the going market price of $8.03/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Investors in Calithera Biosciences, Inc. saw new options begin trading this week, for the April 20th expiration.
Investors in Calithera Biosciences, Inc. saw new options become available this week, for the February 2018 expiration.
Investors in Calithera Biosciences, Inc. saw new options become available this week, for the January 2018 expiration.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 278,209 share increase in total short interest for Calithera Biosciences, Inc. , to 2,910,428, an increase of 10.57% since 10/13/2017.
Calithera to Webcast Clinical Update on CB-839 on November 11, 2017
-Calithera to Host Conference Call Today at 1:30 p.m. Pacific Time/ 4:30 p.m. Eastern Time
In recent trading, shares of Calithera Biosciences, Inc. have crossed above the average analyst 12-month target price of $19.00, changing hands for $20.00/share.
There is nothing to indicate that this period of chaotic rotation has ended.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.